| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,074 |
6,575 |
$1.36M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,674 |
11,094 |
$1.35M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,385 |
3,915 |
$848K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,639 |
1,545 |
$122K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,019 |
2,595 |
$119K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,128 |
5,599 |
$110K |
| 80053 |
Comprehensive metabolic panel |
8,234 |
7,130 |
$97K |
| 71045 |
Radiologic examination, chest; single view |
4,526 |
4,048 |
$95K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
346 |
307 |
$84K |
| 70450 |
Computed tomography, head or brain; without contrast material |
888 |
783 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,145 |
4,905 |
$66K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,158 |
7,837 |
$52K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,141 |
950 |
$49K |
| 81025 |
|
4,240 |
3,931 |
$42K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,887 |
1,663 |
$37K |
| 83880 |
|
1,617 |
1,374 |
$37K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,756 |
1,630 |
$34K |
| 84484 |
|
3,359 |
2,620 |
$29K |
| 83690 |
|
4,238 |
3,775 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
861 |
791 |
$23K |
| 81001 |
|
6,001 |
5,445 |
$22K |
| G0378 |
Hospital observation service, per hour |
156 |
122 |
$19K |
| 87088 |
|
2,487 |
2,249 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,804 |
1,533 |
$14K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
55 |
50 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
770 |
608 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,450 |
1,251 |
$10K |
| 87081 |
|
1,198 |
1,158 |
$10K |
| 76801 |
|
84 |
76 |
$9K |
| 59025 |
Fetal non-stress test |
258 |
203 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
203 |
179 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
695 |
603 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,118 |
1,873 |
$8K |
| 83605 |
|
1,032 |
841 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
714 |
497 |
$6K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
195 |
186 |
$6K |
| 85730 |
|
1,252 |
1,075 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
806 |
605 |
$3K |
| 85610 |
|
1,351 |
1,164 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
383 |
317 |
$3K |
| 83735 |
|
604 |
492 |
$3K |
| 82550 |
|
661 |
573 |
$3K |
| 84702 |
|
186 |
160 |
$2K |
| 87807 |
|
258 |
243 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
195 |
186 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
110 |
81 |
$2K |
| J3490 |
Unclassified drugs |
2,360 |
1,633 |
$2K |
| 81003 |
|
991 |
901 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
110 |
68 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
330 |
211 |
$1K |
| 87186 |
|
177 |
147 |
$985.64 |
| 87040 |
|
110 |
76 |
$963.73 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
349 |
323 |
$906.11 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
746 |
593 |
$888.19 |
| 36415 |
Collection of venous blood by venipuncture |
4,667 |
3,670 |
$782.42 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
40 |
31 |
$661.55 |
| 86900 |
|
268 |
249 |
$637.39 |
| 86901 |
|
252 |
235 |
$600.19 |
| 71046 |
Radiologic examination, chest; 2 views |
24 |
24 |
$545.25 |
| 99001 |
|
25 |
24 |
$487.80 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15 |
15 |
$288.09 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
27 |
$281.85 |
| 84145 |
|
13 |
13 |
$279.38 |
| 86850 |
|
19 |
14 |
$214.69 |
| J7050 |
Infusion, normal saline solution, 250 cc |
38 |
28 |
$170.05 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
33 |
25 |
$162.99 |
| A9150 |
Non-prescription drugs |
194 |
142 |
$134.91 |
| 87077 |
|
18 |
13 |
$126.26 |
| 85379 |
|
17 |
12 |
$116.94 |
| 85027 |
|
36 |
24 |
$86.78 |
| 36000 |
|
14 |
12 |
$77.16 |
| 81002 |
|
44 |
36 |
$62.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
14 |
$22.10 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
253 |
212 |
$15.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
21 |
16 |
$13.79 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
921 |
361 |
$12.64 |
| 82962 |
|
1,191 |
649 |
$2.53 |
| A9270 |
Non-covered item or service |
147 |
88 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
27 |
25 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
38 |
29 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
13 |
$0.00 |
| 36416 |
|
14 |
12 |
$0.00 |
| 85008 |
|
12 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
16 |
13 |
$0.00 |